Paysign, Inc. (NASDAQ:PAYS) Insider Sells $765,228.97 in Stock

Paysign, Inc. (NASDAQ:PAYS - Get Free Report) insider Topline Capital Management, Ll sold 231,187 shares of Paysign stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $3.31, for a total value of $765,228.97. Following the completion of the transaction, the insider now directly owns 5,859,046 shares in the company, valued at approximately $19,393,442.26. This represents a 3.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Topline Capital Management, Ll also recently made the following trade(s):

• On Monday, December 30th, Topline Capital Management, Ll sold 227,084 shares of Paysign stock. The shares were sold at an average price of $3.07, for a total transaction of $697,147.88.

Paysign Stock Down 1.6 %

NASDAQ:PAYS traded down $0.05 during trading hours on Tuesday, reaching $3.02. The company had a trading volume of 231,026 shares, compared to its average volume of 247,984. Paysign, Inc. has a twelve month low of $2.40 and a twelve month high of $5.59. The firm has a market cap of $161.71 million, a price-to-earnings ratio of 20.13 and a beta of 0.93. The business's 50-day simple moving average is $3.41 and its two-hundred day simple moving average is $4.02.

Paysign (NASDAQ:PAYS - Get Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of $0.01 by $0.02. Paysign had a return on equity of 30.64% and a net margin of 14.28%. The company had revenue of $15.26 million during the quarter, compared to the consensus estimate of $14.96 million. During the same period last year, the business posted $0.02 EPS. As a group, equities analysts predict that Paysign, Inc. will post 0.21 earnings per share for the current year.

Institutional Investors Weigh In On Paysign

Several hedge funds and other institutional investors have recently modified their holdings of PAYS. Renaissance Technologies LLC grew its position in Paysign by 25.0% in the 2nd quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company's stock valued at $6,484,000 after purchasing an additional 301,000 shares during the period. Royce & Associates LP acquired a new position in shares of Paysign during the third quarter valued at about $814,000. Rhumbline Advisers grew its holdings in shares of Paysign by 25.1% during the second quarter. Rhumbline Advisers now owns 35,835 shares of the company's stock valued at $154,000 after buying an additional 7,190 shares during the last quarter. Joule Financial LLC bought a new stake in shares of Paysign during the third quarter worth about $1,478,000. Finally, BNP Paribas Financial Markets raised its holdings in shares of Paysign by 257.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company's stock worth $164,000 after acquiring an additional 32,245 shares during the last quarter. Institutional investors own 25.89% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Lake Street Capital started coverage on shares of Paysign in a research report on Friday, December 20th. They set a "buy" rating and a $6.00 price target on the stock. Barrington Research restated an "outperform" rating and set a $7.00 target price on shares of Paysign in a research report on Monday, November 4th. Four investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of "Buy" and an average target price of $6.13.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.